Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dose versus evening-before bowel preparation with loperamide for colonoscopy
ACTRN12618001388202Phase 3Recruiting
- Sponsor
- Dr Sameer Memon
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sodium picosulfate + magnesium oxide + citric acid, loperamide and bisacodyl (2 arms), sponsored by Dr Sameer Memon. Primary endpoint: Quality of bowel cleanliness. Started Nov 2018; status: recruiting.
02
Drugs
sodium picosulfate + magnesium oxide + citric acidloperamidebisacodyl
Beyond the preview
Go deeper on ACTRN12618001388202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001388202.